1. Home
  2. GSIW vs TRAW Comparison

GSIW vs TRAW Comparison

Compare GSIW & TRAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GSIW
  • TRAW
  • Stock Information
  • Founded
  • GSIW 2016
  • TRAW 1998
  • Country
  • GSIW Hong Kong
  • TRAW United States
  • Employees
  • GSIW N/A
  • TRAW N/A
  • Industry
  • GSIW
  • TRAW
  • Sector
  • GSIW
  • TRAW
  • Exchange
  • GSIW Nasdaq
  • TRAW NYSE
  • Market Cap
  • GSIW 12.3M
  • TRAW 10.1M
  • IPO Year
  • GSIW 2023
  • TRAW 2013
  • Fundamental
  • Price
  • GSIW $0.48
  • TRAW $2.32
  • Analyst Decision
  • GSIW
  • TRAW
  • Analyst Count
  • GSIW 0
  • TRAW 0
  • Target Price
  • GSIW N/A
  • TRAW N/A
  • AVG Volume (30 Days)
  • GSIW 91.3K
  • TRAW 48.8K
  • Earning Date
  • GSIW 12-31-2024
  • TRAW 03-31-2025
  • Dividend Yield
  • GSIW N/A
  • TRAW N/A
  • EPS Growth
  • GSIW N/A
  • TRAW N/A
  • EPS
  • GSIW N/A
  • TRAW N/A
  • Revenue
  • GSIW $1,313,795.00
  • TRAW $226,000.00
  • Revenue This Year
  • GSIW N/A
  • TRAW $3.81
  • Revenue Next Year
  • GSIW N/A
  • TRAW N/A
  • P/E Ratio
  • GSIW N/A
  • TRAW N/A
  • Revenue Growth
  • GSIW N/A
  • TRAW N/A
  • 52 Week Low
  • GSIW $0.43
  • TRAW $2.01
  • 52 Week High
  • GSIW $12.30
  • TRAW $24.75
  • Technical
  • Relative Strength Index (RSI)
  • GSIW 47.04
  • TRAW 31.50
  • Support Level
  • GSIW $0.45
  • TRAW $2.52
  • Resistance Level
  • GSIW $0.52
  • TRAW $2.69
  • Average True Range (ATR)
  • GSIW 0.03
  • TRAW 0.27
  • MACD
  • GSIW 0.00
  • TRAW 0.08
  • Stochastic Oscillator
  • GSIW 58.82
  • TRAW 25.20

About GSIW Garden Stage Limited

Garden Stage Ltd is a Hong Kong-based financial services provider principally engaged in the provision of placing and underwriting services; securities dealing and brokerage services; and asset management services. Its business is carried out through its wholly owned Operating Subsidiaries: a) I Win Securities, which is licensed to conduct Type 1 (dealing in securities) regulated activities under the SFO in Hong Kong, and b) I Win Asset Management, which is licensed to conduct Type 4 (advising on securities) and Type 9 (asset management) regulated activities under the SFO in Hong Kong.

About TRAW TRAWS PHARMA INC

Traws Pharma Inc is a biopharmaceutical company focused on developing antivirals for influenza, COVID and other respiratory infections and narazaciclib.

Share on Social Networks: